Identifying optimal candidates for postoperative adjuvant therapy among regional persistent/recurrent nasopharyngeal carcinoma patients after neck dissection.

BMC Cancer · 2022 · PMC9632143 · PMID 36329397

Europe PMC DOI

hedged sentence

0.0720

closest p · 1.4× alpha

0.0720

boldest claim

The sentences

near-significantP = 0.072so close (0.05 < p ≤ 0.1)

Additionally, patients in the ND + PAT group were associated with higher preoperative EBV DNA level than patients in the ND alone group, but to a near-significant extent ( P = 0.072).

also in 2,306 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.